Taxane derivatives for targeted therapy of cancer

Details Taxane derivatives for targeted therapy of cancer Taxane derivatives for targeted therapy of cancer

A - Human Necessities

61

K

A61K 38/00 (2006.01) A61K 38/04 (2006.01) A61K 38/16 (2006.01) A61K 47/48 (2006.01)

Patent

CA 2362937

The present invention describes for the first time the design and synthesis of a soluble tumor-directed paclitaxel prodrug which may establish a new mode of utilization of the taxane class of anticancer agents in cancer therapy.

L'invention concerne la conception et la synthèse d'un promédicament paclitaxel soluble pour thérapie ciblée contre une tumeur, pouvant déboucher sur un nouveau mode d'utilisation des anticancéreux de type taxane dans le traitement du cancer.

Affiliated with

Also associated with

Rating

Taxane derivatives for targeted therapy of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Taxane derivatives for targeted therapy of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Taxane derivatives for targeted therapy of cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1877620